VYGR R&D to Revenue

Voyager Therapeutics Inc · R&D to Revenue

VYGR logo

VYGR R&D to Revenue

Latest reported333.57%
VYGR FY R&D/Revenue (0.00% → 333.57%)
High-resolution chart · PNG

VYGR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Voyager Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
333.5662%
159.208%
36.8676%
148.5418%
197.2123%
63.5507%
114.6986%
851.8834%
614.3069%
297.1097%
159.6804%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.